Tuesday, May 6, 2025

CCII Research Ding and Yaddanapuddi

Jun Yan, center, leads research to better understand immune dysregulation leading to acute respiratory distress in COVID-19 and other conditions. Yan and colleagues, including Anne Geller, right, discovered a specific type of immune cell associated with immune system overreaction in 2020 while treating COVID-19 patients. The work recently was funded by $5.8 in NIH grants.

UofL researchers Kavitha Yaddanapuddi, Ph.D., (left) and Chuanlin Ding, Ph.D., use a mass cytometer to help improve the effectiveness of cancer immunotherapies.

Jun Yan, center, leads research to better understand immune dysregulation leading to acute respiratory distress in COVID-19 and other conditions. Yan and colleagues, including Anne Geller, right, discovered a specific type of immune cell associated with immune system overreaction in 2020 while treating COVID-19 patients. The work recently was funded by $5.8 in NIH grants.